Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

AI-Assisted Interpretation of Ultra-Widefield Retinal Images

Prospective Multi-Center Evaluation of AI-Assisted Interpretation of Ultra-Widefield Retinal Images in a Multi-Reader Crossover Study

The goal of this prospective observational study is to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

The main questions it aims to answer are:

whether AI assistance improves the diagnostic performance of ophthalmologists in detecting retinal findings on UWF retinal images; whether AI assistance improves sensitivity, specificity, and inter-reader agreement across clinicians with different levels of experience.

Approximately 600 UWF retinal images prospectively collected from multiple ophthalmic centers in China will be included. Images will be independently annotated by expert retinal specialists to establish reference labels for retinal finding categories.

Four ophthalmologists with different levels of clinical experience, including one senior retinal specialist and three junior ophthalmologists, will participate in a crossover multi-reader study.

For each clinician, the dataset will be randomly divided into two equal subsets. During the first reading session, clinicians will evaluate one subset without AI assistance and the other subset with AI assistance. After a washout interval of at least two weeks, the reading conditions will be reversed in a second reading session with independently randomized image order.

Under the AI-assisted condition, clinicians will be provided with category-level AI prediction probabilities for retinal findings. No localization maps, heatmaps, segmentation overlays, or automated diagnostic recommendations will be displayed. Clinicians will retain full autonomy over final decisions.

Reader performance under AI-assisted and unaided conditions will be compared using expert reference annotations as the ground truth.

Studieoversikt

Detaljert beskrivelse

This study is a prospective multi-center observational reader study designed to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

Approximately 600 UWF retinal images will be prospectively collected from multiple ophthalmic centers in China. Images will be acquired using clinically routine UWF retinal imaging systems and will include a broad spectrum of retinal diseases and retinal findings encountered in real-world clinical practice.

All images will undergo independent expert annotation by retinal specialists to establish reference labels for retinal finding categories. These expert annotations will serve as the reference standard for subsequent performance evaluation.

Four ophthalmologists with different levels of clinical experience will participate in the reader study, including:

one senior retinal specialist with approximately five years of retinal clinical experience; three junior ophthalmologists with approximately two years of ophthalmology residency training.

A randomized crossover multi-reader design will be implemented to minimize recall bias and balance reading conditions.

For each clinician, the image dataset will be randomly divided into two equal subsets (subset A and subset B; approximately 300 images each).

During Round 1:

subset A will be interpreted without AI assistance; subset B will be interpreted with AI assistance.

After a washout interval of at least two weeks, the reading conditions will be reversed during Round 2:

subset A will be interpreted with AI assistance; subset B will be interpreted without AI assistance.

Image order will be independently randomized for each session and each clinician.

Under the unaided condition, clinicians will evaluate retinal images using standard clinical interpretation without AI output.

Under the AI-assisted condition, clinicians will receive category-level AI prediction probabilities for retinal finding categories. The AI output will provide probabilistic confidence scores only and will not include lesion localization maps, heatmaps, segmentation overlays, or automated binary recommendations.

Clinicians will remain blinded to the expert reference labels and to the interpretations of other readers. Final diagnostic decisions will be independently determined by each clinician.

The primary analysis will compare diagnostic performance between unaided and AI-assisted conditions, including sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and inter-reader agreement.

Studietype

Observasjonsmessig

Registrering (Faktiske)

462

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Kina
        • Chongqing Huaxia Eye Hospital
    • Fujian
      • Fuzhou, Fujian, Kina, 361000
        • Fuzhou Eye Hospital
      • Xiamen, Fujian, Kina, 361000
        • Xiamen Eye Center of Xiamen University
    • Hebei
      • Hengshui, Hebei, Kina
        • Hengshui Tongrui Eye Hospital
    • Shandong
      • Heze, Shandong, Kina
        • Heze Huaxia Eye Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Participants undergoing clinically indicated ultra-widefield retinal imaging at participating ophthalmic centers in China, including individuals with diverse retinal diseases and retinal findings encountered in real-world clinical practice.

Beskrivelse

Inclusion Criteria:

  • Participants undergoing ultra-widefield retinal imaging at participating ophthalmic centers;

Exclusion Criteria:

  • Poor-quality or ungradable retinal images;

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
AI-Assisted Interpretation
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Unaided Interpretation
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Sensitivity for retinal finding detection
Tidsramme: through study completion, an average of 2 months
Sensitivity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions using expert annotations as the reference standard.
through study completion, an average of 2 months
Specificity for retinal finding detection
Tidsramme: through study completion, an average of 2 months
Specificity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions.
through study completion, an average of 2 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Area under the receiver operating characteristic curve (AUC)
Tidsramme: through study completion, an average of 2 months
The AUC quantifies the overall ability to correctly distinguish the presence versus absence of predefined retinal findings on ultra-widefield retinal images. AUC values range from 0.5 (no discriminative ability) to 1.0 (perfect discrimination). Clinician interpretations will be compared with an expert-adjudicated reference standard under AI-assisted and unaided conditions.
through study completion, an average of 2 months
Inter-reader agreement
Tidsramme: At study completion (up to 3 months)
Agreement among participating clinicians in classifying predefined retinal findings on ultra-widefield retinal images. Agreement will be quantified using Cohen's kappa coefficient (for pairwise comparisons) or Fleiss' kappa coefficient (for multiple readers). Kappa values range from 0 (no agreement beyond chance) to 1 (perfect agreement).
At study completion (up to 3 months)
Diagnostic performance improvement among junior ophthalmologists
Tidsramme: At study completion (up to 3 months)
Improvement in diagnostic performance of junior ophthalmologists when interpreting ultra-widefield retinal images with AI assistance compared with unaided interpretation, measured by changes in sensitivity, specificity, accuracy, and AUC using the expert-adjudicated reference standard.
At study completion (up to 3 months)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Xiuju Chen, Xiamen Eye Center of Xiamen University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. januar 2026

Primær fullføring (Faktiske)

1. februar 2026

Studiet fullført (Faktiske)

10. februar 2026

Datoer for studieregistrering

Først innsendt

5. juni 2026

Først innsendt som oppfylte QC-kriteriene

10. juni 2026

Først lagt ut (Faktiske)

16. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • XMYKZX-KY-2026-008

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

De-identified individual participant data underlying the results reported in this study, including retinal imaging data and associated annotations, may be made available upon reasonable request to the corresponding investigator following publication, subject to institutional ethics approval, data-sharing agreements, and applicable data governance and privacy regulations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere